ApicHope Pharmaceutical Co., Ltd

Shenzhen Stock Exchange 300723.SZ

ApicHope Pharmaceutical Co., Ltd Shareholders' Equity for the year ending December 31, 2023: USD 355.24 M

ApicHope Pharmaceutical Co., Ltd Shareholders' Equity is USD 355.24 M for the year ending December 31, 2023, a 19.51% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

ApicHope Pharmaceutical Co., Ltd Shareholders' Equity for the year ending December 31, 2022 was USD 297.24 M, a 0.77% change year over year.
ApicHope Pharmaceutical Co., Ltd Shareholders' Equity for the year ending December 31, 2021 was USD 294.98 M, a 29.67% change year over year.
ApicHope Pharmaceutical Co., Ltd Shareholders' Equity for the year ending December 31, 2020 was USD 227.49 M, a 19.21% change year over year.
ApicHope Pharmaceutical Co., Ltd Shareholders' Equity for the year ending December 31, 2019 was USD 190.83 M, a 1.08% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Shenzhen Stock Exchange: 300723.SZ

ApicHope Pharmaceutical Co., Ltd

CEO	Mr. Hanxiong Li
IPO Date	Nov. 16, 2017
Location	China
Headquarters	No. 27, Yunrun Building
Employees	1,676
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies Personal Care

Description

ApicHope Pharmaceutical Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers anti-infection, pediatric, cardiovascular, genitourinary, respiratory, liver and digestion, and dermatological products, as well as anti-inflammatory and analgesic products. The company was formerly known as Yipinhong Pharmaceutical Co.,Ltd and changed its name to ApicHope Pharmaceutical Co., Ltd in December 2021. ApicHope Pharmaceutical Co., Ltd was founded in 2002 and is based in Guangzhou, China.

Key trends

Past 5 years